Aldebaran Capital, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001448430

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q2 2024 · 36 positions · Total reported value $107.40M · Top-10 concentration 76.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 25.6% · 4 new · 7 cut · 0 exited

Active Share (vs S&P 500): 89.6% · vs QQQ: 94.2% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2024 13F filing, Aldebaran Capital, LLC disclosed 36 equity positions with a combined reported value of $107.40M. The filing implies a focused portfolio: its ten largest positions account for 76.8% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q2 2024 were BRKB ($17.92M), OXY ($11.01M), BG ($10.84M). By sector, the heaviest allocations are Energy 20.7%, Technology 11.8%. Versus the prior quarter, allocation shifted toward Health Care (+3.3pp), Technology (+0.8pp) and away from Energy (-1.0pp), Other (-2.8pp).

Versus the prior quarter, Aldebaran Capital, LLC opened 4 new positions, trimmed 7 and fully exited 0, a turnover rate of 25.6% of positions. The portfolio's overlap with the prior quarter was 86% of names.

The largest new positions opened in Q2 2024 were ACRS ($943.97K), TECX ($691.59K), PMVP ($569.01K).

Of the 1 positions fully exited versus the prior quarter, the largest were AVRO ($662.31K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • ACRS ACLARIS THERAPEUTICS INC · $943.97K
  • TECX TECTONIC THERAPEUTIC INC · $691.59K
  • PMVP PMV PHARMACEUTICALS INC · $569.01K
  • AMLX AMYLYX PHARMACEUTICALS INC · $512.63K

Fully Exited (vs previous quarter)

  • AVRO AVROBIO INC · prev qtr: $662.31K

Insider Transactions (Form 4)

Latest Aldebaran Capital, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Aldebaran Capital, LLC is an SEC-registered 13F filer. As of Q2 2026 it reported 39 US equity positions with a combined value of $133.10M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 39 positions · $133.10M reported value (Q2 2026)
  • Top 10 holdings = 60.0% of reported value
  • Largest position: BRKB (BERKSHIRE HATHAWAY INC DEL) at 15.6%
  • Average position size: $3.41M

Sector Tilt

  • Health Care 19.9%
  • Energy 13.8%
  • Consumer Discretionary 9.4%
  • (classified holdings cover 70% of value)

Quarterly Activity

  • Q2 2026: 3 added, 24 reduced, 4 exited
  • 12 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Energy 20.7%
Technology 11.8%
Financials 8.0%
Other 31.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 44.05K $17.92M 16.69%
16.69%
Reduce
2 174.61K $11.01M 10.25%
10.25%
Reduce
3 101.52K $10.84M 10.09%
10.09%
Reduce
4 23.91K $10.68M 9.95%
9.95%
Add
5 7.78K $7.05M 6.56%
6.56%
Hold
6 145.26K $5.78M 5.38%
5.38%
Hold
7 923.94K $5.12M 4.77%
4.77%
Add
8 127.67K $4.86M 4.53%
4.53%
Reduce
9 38.76K $4.68M 4.36%
4.36%
Reduce
10 29.12K $4.56M 4.24%
4.24%
Reduce
11 157.34K $3.20M 2.98%
2.98%
Reduce
12 11.91K $2.41M 2.24%
2.24%
Hold
13 152.71K $1.82M 1.69%
1.69%
Hold
14 43.16K $1.78M 1.66%
1.66%
Reduce
15 40.79K $1.63M 1.52%
1.52%
Reduce
16 32.31K $1.57M 1.46%
1.46%
Reduce
17 43.76K $1.56M 1.45%
1.45%
Reduce
18 2 $1.22M 1.14%
1.14%
Hold
19 63.43K $1.06M 0.99%
0.99%
Reduce
20 9.68K $1.05M 0.98%
0.98%
Add
21 858.15K $943.97K 0.88%
0.88%
New
22 5.41K $753.91K 0.70%
0.70%
Reduce
23 41.99K $691.59K 0.64%
0.64%
New
24 447.62K $675.90K 0.63%
0.63%
Add
25 13.31K $637.69K 0.59%
0.59%
Reduce
26 351.24K $569.01K 0.53%
0.53%
New
27 269.80K $512.63K 0.48%
0.48%
New
28 29.98K $500.05K 0.47%
0.47%
Reduce
29 10.12K $410.47K 0.38%
0.38%
Hold
30 3.60K $360.83K 0.34%
0.34%
Hold
31 8.34K $343.23K 0.32%
0.32%
Reduce
32 13.27K $310.10K 0.29%
0.29%
Reduce
33 20.65K $258.95K 0.24%
0.24%
Hold
34 1.91K $219.65K 0.20%
0.20%
Hold
35 1.33K $211.59K 0.20%
0.20%
Hold
36 1.26K $207.87K 0.19%
0.19%
Hold

FAQ

What did Aldebaran Capital, LLC buy in 2024-Q2?

In its 2024-Q2 13F filing, Aldebaran Capital, LLC reported 36 equity positions worth $107.40M in aggregate; its largest disclosed positions were BRKB ($17.92M), OXY ($11.01M), BG ($10.84M).

How large is Aldebaran Capital, LLC's portfolio?

Aldebaran Capital, LLC reported $107.40M of long equity holdings across 36 positions as of 2024-Q2. Top-10 holdings account for 76.8% of reported value.

What is Aldebaran Capital, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/aldebaran-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →